Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00460499
Status:
COMPLETED
Last Update Posted:
2015-06-23
First Post:
2007-04-12
Brief Title:
Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic Control
Sponsor:
American Heart Association
Organization:
American Heart Association
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2015-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study seeks to determine whether varying the dose of insulin and glucose in diabetic patients during coronary bypass surgery will improve outcomes in these patients
Detailed Description:
Our previous study has shown that maintaining serum glucose between 120-180mgdl in the perioperative period during CABG surgery in diabetic patients improves outcomes The purpose of this trial is 1 to determine whether outcomes can be improved by altering the content of glucose or insulin in these solutions 2to determine the effect of these solutions and glycemic control on the inflammatory response of arterial and venous conduits used during surgery 3 to determine whether the beneficial effects of improved glycemic control can be correlated with changes in the inflammatory response
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None